2BBBullish & Bearish
Organon & Co. Common Stock (OGN) trades on NYSE. It operates in the Health Care sector, Drug Manufacturers - General industry. Its current 2BB score is 19 out of 100.
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Organon & Co. Common Stock’s current 2BB score is 19 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 22 | Weak |
| Quality | 100 | Very Strong |
| Risk | 52 | Moderate |
| Headquarters | Jersey City, New Jersey, United States |
| Founded | 1923 |
| Employees | 10K |
| P/E ratio | 14.47 |
| 52-week range | $5.69 – $13.60 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-10 | — | 0.7592 | — | $1.55B |
| 2026-11-09 | — | 0.9364 | — | $1.58B |
| 2026-08-11 | — | 0.9273 | — | $1.58B |
| 2026-04-29 | — | 0.8375 | — | $1.51B |